By CHAD BRAY
The Irish pharmaceutical company has offered to pay $46 a share in cash for Hyperion, representing a 7.6 percent premium to its closing price on Friday.
Published: March 31, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1EUjZS0
from WordPress http://ift.tt/1MndUa4
via Hadi Aboukhater
No comments:
Post a Comment